Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 222

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

Letendre, Scott L., McCutchan, J. Allen, Childers, Meredith E., Woods, Steven P., Lazzaretto, Deborah, Heaton, Robert K., Grant, Igor, Ellis, Ronald J., the HNRC Group·2004·Annals of Neurology

Abstract

The benefits of combination antiretroviral therapy (ART) for HIV cognitive disorders vary substantially between individuals. This study evaluated whether cerebrospinal fluid (CSF) drug penetration and CSF virological suppression influence the extent of neuropsychological (NP) improvement during ART. Overall performance on a battery of NP tests administered at baseline and follow‐up (median 15 weeks) was computed by using the global deficit score (GDS) methods in 31 cognitively impaired, HIV‐infected individuals who began new ART regimens. Virological suppression (attaining undetectable viral load by RT‐PCR at follow‐up) was assessed separately for plasma and CSF. Subjects on regimens containing greater numbers of CSF‐penetrating drugs showed significantly greater reduction in CSF viral load. Subjects attaining CSF virological suppression demonstrated greater GDS improvement than those who did not (median GDS change, 0.62 vs 0.23; p = 0.01). A similar trend for plasma did not reach statistical significance (p = 0.053). NP improvement was greater in ART‐naive versus treatment‐experienced subjects. In a multivariate model (overall p = 0.0008), significant, independent predictors of GDS reduction were CSF HIV RNA suppression, baseline antiretroviral history, and their interaction. Including CSF‐penetrating drugs in the ART regimen and monitoring CSF viral load may be indicated for individuals with HIV‐associated cognitive impairment Ann Neurol 2004.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.20198

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 222

Metadata

Authors
Letendre, S. L., McCutchan, J. A., Childers, M. E., Woods, S. P., Lazzaretto, D., Heaton, R. K., Grant, I., Ellis, R. J., & the HNRC Group
Venue
Annals of Neurology
Publisher
Wiley
Published
2004-08-31
Volume
56
Issue
3
Pages
416-423
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2048226899
Cited by
222
References
3
FWCI
3.82
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. https://app.cochat.ai/papers/10.1002/ana.20198
The paper
Letendre, S. L., McCutchan, J. A., Childers, M. E., Woods, S. P., Lazzaretto, D., Heaton, R. K., Grant, I., Ellis, R. J., & the HNRC Group. (2004). Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Annals of Neurology. https://doi.org/10.1002/ana.20198

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.